课题基金 / 基金详情

INNOVATION FOR TISSUE-SPECIFIC RADIO-SENCITIZATION OF SELECTIVE INHIBITOR OF CYCLO-OXYGENASE 2 (COX-2)

INNOVATION FOR TISSUE-SPECIFIC RADIO-SENCITIZATION OF SELECTIVE INHIBITOR OF CYCLO-OXYGENASE 2 (COX-2)
环加氧酶 2 (COX-2) 选择性抑制剂的组织特异性放射增敏创新
批准号:
14570858
负责人:
MATSUMOTO Akira
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

MATSUMOTO Akira的其他基金

相似基金

相关文献

中文摘要
翻译
一个众所周知的事实是,活跃复制的肿瘤细胞和分化的无复制活性的神经元在放射敏感性上存在很大差异。本研究以环氧合酶-2(COX-2)抑制剂和羧基肽酶B(HBCPB)为研究对象,探讨了COX-2和HBCPB在细胞凋亡诱导中的作用。COX-2研究:以人血管肉瘤细胞株(ISO-HAS)为研究对象,研究了照射和选择性COX-2抑制剂NS-389联合应用对肿瘤生长和血管生成的影响。COX-2效应与血管内皮生长因子蛋白表达的关系NS-389呈剂量依赖性地降低细胞存活率,照射后VEGF-蛋白表达也呈剂量依赖性增加,联合使用NS-398可抑制这一作用。由此可见,NS-389与辐射具有共用效应,其细胞生长抑制作用与VEGF有关。HBCPB研究:以大鼠海马神经元原代培养体系为研究对象,以非复制细胞为典型例子。在该系统中,我们分析了β-淀粉样蛋白1-42低聚物的神经毒性及其被人脑羧基肽酶B(HBCPB)解离后的细胞凋亡诱导作用,结果表明该系统对COX-2前列腺素谱系无影响,提示该系统是选择性细胞死亡以维持内环境稳定的独立调节系统。
英文摘要
It is a well-known fact that there iis a great difference in radiosensitivity between actively replicating tumor cell and differentiated neurons without replicating activity. In this research project, we focused on cyclo-oxygenase 2 (COX-2) inhibitors, whose inhibitory action of cell replication is recognized in many tumor cell linse, and carboxypeptidase B (HBCPB) which exhibits inhibitory activity for cell toxicity be dissociation of beta-amyloid oligomer, and snslyzed their functions with regard to apoptosis induction.COX-2 study : Using human hemangiosarcoma cell line (ISO-HAS), following analyses were performed.Effects in tumor growth and angiogenesis by co-usage of irradiation and NS-389, a selective COX-2 inhibitor.Relationship of COX-2 effect and VEGF protein expression.As for results, cell viability was decreased by NS-389 in a dose dependent fashion, and the VEGF-protein expression was increased by irradiation also in a dose-dependent manner, which was inhibited by co-usage of NS-398. Therefore, it seems that NS-389 has a co-usage effect with irradiation, and its cell growth inhibitory effect is relevant to VEGF.HBCPB study : As a typical example of non-replicating cell, using rat hippocampus primary neuron culture system was used. In this system, neuro-toxicity of beta-amyloid 1-42 oligomer, and its dissociation by human brain carboxypeptidase B (HBCPB) were analyzed especially with respect to apoptosis induction.As a result, this system induced no effects in the COX-2 prostaglandin lineage, and suggests that these are independent regulation system for selective cell death to keep homeostasis.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
Kaji, Y. et al.: "Proton two-dimensional chemical shift imaging for evaluation of prostate cancer : External surface coil vs. endorectal"J.Magn.Reson.Imaging. 16. 697-706 (2002)
Kaji, Y. 等人:“用于评估前列腺癌的质子二维化学位移成像:外表面线圈与直肠内”J.Magn.Reson.Imaging。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuyama, S., Matsumoto, A.: "Epibetidine induces long-term ostentation (LTP) via activation of α4β2 nicotinic acetyl-Choline receptors (nAChRs) in vivo in the intact mouse dentate gyrus : both α4β2"J.Pharmacol.Sci.. 93. 180-187 (2003)
Matsuyama, S., Matsumoto, A.:“Epibetidine 通过激活完整小鼠齿状回体内的 α4β2 烟碱乙酰胆碱受体 (nAChR) 来诱导长期炫耀 (LTP):两者都是 α4β2”J.Pharmacol.Sci。 . 93. 180-187 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuyama, S., Matsumoto, A.: "Epibetidine induces long-term potentiation (LTP) via activation of α4β2 nicotinic acetyl-Choline receptors (nAChRs) in vivo in the intact mouse dentate gyrus : both α7 and α4β2"J.Pharmacol.Sci.. 93. 180-187 (2003)
Matsuyama, S., Matsumoto, A.:“Epibetidine 通过激活完整小鼠齿状回体内的 α4β2 烟碱乙酰胆碱受体 (nAChR) 来诱导长时程增强 (LTP):α7 和 α4β2”J.Pharmacol。科学.. 93. 180-187 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuyama, S.et al.: "Impaired long-term potentiation in vivoin the dentate gyrus of pituitary adenylate cyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice."Neuroreport. 14. 2095-2098 (2003)
Matsuyama, S.等人:“垂体腺苷酸环化酶激活多肽 (PACAP) 或 PACAP 1 型受体突变小鼠的齿状回体内长期增强作用受损。”Neurreport。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Smart-gel based synthetic artificial pancreas
    • 批准号:
      25560220
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    Posttranscriptional regulation of clock genes by ABC protein
    • 批准号:
      24570199
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.58万
    • 财政年份:
      2012
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    Development of Integrated Transistor Based device for Monitoring of Enzymatic Activities as Next-generation Platform for Apoptosis Pathways Analysis
    • 批准号:
      23680051
    • 项目类别:
      Grant-in-Aid for Young Scientists (A)
    • 资助金额:
      $18.05万
    • 财政年份:
      2011
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    Civil Society, Nationstate and War in Modern Germany
    • 批准号:
      21520738
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      MATSUMOTO Akira
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: